Literature DB >> 9403242

Vitiligo.

R A Schwartz1, C K Janniger.   

Abstract

Vitiligo is a common disorder afflicting people of all ages around the world. It produces milky white patches of depigmentation that cause significant morbidity due to cosmetic disfigurement. One should distinguish segmental from nonsegmental vitiligo, and be aware the latter is associated with an extremely small risk of associated autoimmune disorders. New therapeutic options offer some additional hope to patients with vitiligo, but more progress in the understanding of its pathogenesis and therapy is still needed.

Entities:  

Mesh:

Year:  1997        PMID: 9403242

Source DB:  PubMed          Journal:  Cutis        ISSN: 0011-4162


  4 in total

1.  Patients affected by vitiligo and autoimmune diseases do not show antibodies interfering with the activity of the melanocortin 1 receptor.

Authors:  P Agretti; G De Marco; D Sansone; C Betterle; G Coco; A Dimida; E Ferrarini; A Pinchera; P Vitti; M Tonacchera
Journal:  J Endocrinol Invest       Date:  2010-03-22       Impact factor: 4.256

2.  A Case of Vitiligo after Kawasaki's Disease.

Authors:  Han Kyoung Cho; Lucy Youngmin Eun; Ji-Sun Song; Won Hyoung Kang; Byung In Ro
Journal:  Ann Dermatol       Date:  2009-02-28       Impact factor: 1.444

3.  Vitiligo at Injection Site of PEG-IFN-α 2a in Two Patients with Chronic Hepatitis C: Case Report and Literature Review.

Authors:  V Arya; M Bansal; L Girard; S Arya; A Valluri
Journal:  Case Rep Dermatol       Date:  2010-08-27

4.  Prevalence of thyroid function test abnormalities and thyroid autoantibodies in children with vitiligo.

Authors:  Fatma Sule Afsar; Figen Isleten
Journal:  Indian J Endocrinol Metab       Date:  2013-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.